OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 97 filers reported holding OLEMA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $56,000 | +124.0% | 4,508 | +60.9% | 0.00% | – |
| Q2 2023 | $25,000 | +2400.0% | 2,801 | +682.4% | 0.00% | – |
| Q1 2023 | $1,000 | – | 358 | +336.6% | 0.00% | – |
| Q4 2022 | $0 | – | 82 | +10.8% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 74 | -95.3% | 0.00% | – |
| Q1 2022 | $7,000 | -99.4% | 1,576 | -98.7% | 0.00% | – |
| Q4 2021 | $1,120,000 | +1477.5% | 119,687 | +4522.9% | 0.00% | – |
| Q3 2021 | $71,000 | +82.1% | 2,589 | +85.1% | 0.00% | – |
| Q2 2021 | $39,000 | +5.4% | 1,399 | +27.1% | 0.00% | – |
| Q1 2021 | $37,000 | – | 1,101 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $15,238,000 | 2.80% |
| Fairmount Funds Management LLC | 2,669,300 | $10,864,000 | 2.49% |
| BVF INC/IL | 7,611,503 | $30,979,000 | 1.50% |
| Vivo Capital, LLC | 1,689,515 | $6,876,000 | 0.69% |
| Cormorant Asset Management, LP | 2,082,000 | $8,474,000 | 0.64% |
| Newtyn Management, LLC | 500,000 | $2,035,000 | 0.39% |
| Kynam Capital Management, LP | 249,229 | $1,014,000 | 0.26% |
| Monaco Asset Management SAM | 130,000 | $529,000 | 0.23% |
| TANG CAPITAL MANAGEMENT LLC | 318,926 | $1,298,000 | 0.20% |
| Artal Group S.A. | 260,500 | $1,060,000 | 0.06% |